Mannheimia haemolytica and bovine respiratory disease

Animal Health Research Reviews

Volumn 8, Issue 2, 2008, Pages 117-128

  Rice, J A ^a   Carrasco Medina, L ^b   Hodgins, D C ^b   Shewen, P E ^b  

^a DOW AGROSCIENCES LLC   (United States)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

bovine pnemonia; leukotoxin; Mannheimia haemolytica; pneumonic pasteurellosis; respiratory vaccines

Indexed keywords

BACTERIAL VACCINE; EXOTOXIN; LEUKOTOXIN;

ANIMAL; ANIMAL DISEASE; ANIMAL HUSBANDRY; CATTLE; CATTLE DISEASE; IMMUNOLOGY; MANNHEIMIA HAEMOLYTICA; METHODOLOGY; MICROBIOLOGY; NEWBORN; PATHOGENICITY; REVIEW; RISK FACTOR; SEROTYPING;

ANIMAL HUSBANDRY; ANIMALS; ANIMALS, NEWBORN; BACTERIAL VACCINES; BOVINE RESPIRATORY DISEASE COMPLEX; CATTLE; EXOTOXINS; MANNHEIMIA HAEMOLYTICA; PNEUMONIA OF CALVES, ENZOOTIC; RISK FACTORS; SEROTYPING;

EID: 41249091114     PISSN: 14662523     EISSN: 14752654     Source Type: Journal    
DOI: 10.1017/S1466252307001375     Document Type: Review

References (190)

1. Abdullah KM, Udoh EA, Shewen PE and Mellors A (1992). A neutral glycoprotease of Pasteurella haemolytica A1 specifically cleaves O-sialoglycoproteins. Infection and Immunity 60: 56-62.
2. Al-Ghamdi GM, Ames TR, Baker JC, Walker R, Chase CC, Frank GH and Maheswaran SK (2000). Serotyping of Mannheimia haemolytica isolates from the upper Midwest United States. Journal of Veterinary Diagnostic Investigation 12: 576-578.
3. Allan EM, Wiseman A, Gibbs HA and Selman IE (1985). Pasteurella species isolated from bovine respiratory tract and their antimicrobial sensitivity patterns. Veterinary Record 117: 629-631.
4. Allen JW, Viel L, Bateman KG, Rosendal S, Shewen PE and Physick-Sheard P (1991). The microbial flora of the respiratory tract in feedlot calves: associations between nasopharyngeal and bronchoalveolar lavage cultures. Canadian Journal of Veterinary Research 55: 341-346.
5. Ambagala TC, Ambagala AP and Srikumaran S (1999). The leukotoxin of Pasteurella haemolytica binds to beta(2) integrins on bovine leukocytes. FEMS Microbiology Letters 179: 16-67.
6. Ames TR (1997). Dairy calf pneumonia: the disease and its impact. Veterinary Clinics of North America: Food Animal Practice 13: 379-391.
7. Angen O, Mutters R, Caugant DA, Olsen JE and Bisgaard M (1999a). Taxonomic relationships of the [Pasteurella] haemolytica complex as evaluated by DNA-DNA hybridizations and 16S rRNA sequencing with proposal of Mannheimia haemolytica gen. nov., comb. nov., Mannheimia granulomatis comb. nov., Mannheimia glucosida sp. nov., Mannheimia ruminalis sp. nov. and Mannheimia varigena sp. nov. International Journal of Systematic Bacteriology 49: 67-86.
8. Angen O, Quirie M, Donachie W and Bisgaard M (1999b). Investigations on the species specificity of Mannheimia (Pasteurella) haemolytica serotyping. Veterinary Microbiology 65: 283-290.
9. Apley M (1997). Antimicrobial therapy of bovine respiratory disease. Veterinary Clinics of North America: Food Animal Practice 13: 549-574.
10. Apley M (1999). Respiratory disease therapeutics. In: Howard LJ and Smith RA (eds) Current Veterinary Therapy-Food Animal Practice. 4th edn. Philadelphia, PA: W.B. Saunders.
11. Ayalew S, Confer AW and Blackwood ER (2004). Characterization of immunodominant and potentially protective epitopes of Mannheimia haemolytica serotype 1 outer membrane lipoprotein PlpE. Infection and Immunity 72: 7265-7274.
12. Babiuk LA and Acres SD (1984). Models for bovine respiratory disease. In: Loan RW (ed.) Bovine Respiratory Disease, Proceedings of the North American Symposium on Bovine Respiratory Disease. College Station, TX: Texas A&M University Press.
13. Babiuk LA and Campos M (1993). Respiratory vaccines for farm animals. In: Peters AR (ed.) Vaccines for Veterinary Applications. Oxford, UK: Butterworth-Heinemann, pp. 83-115.
14. Bailly P, Tontti E, Hermand P, Cartron JP and Gahmberg CG (1995). The red cell LW blood group protein is an intercellular adhesion molecule, which binds to CD11/ CD18 leukocyte integrins. European Journal of Immunology 25: 3316-3320.
15. Baluyut CS, Simonson RR, Bemrick WJ and Maheswaran SK (1981). Interaction of Pasteurella haemolytica with bovine neutrophils: identification and partial characterization of a cytotoxin. American Journal of Veterinary Research 42: 1920-1926.
16. Bateman KG (1988). Efficacy of a Pasteurella haemolytica vaccine/bacterial extract in the prevention of bovine respiratory disease in recently shipped feedlot calves. Canadian Veterinary Journal 29: 838-839.
17. Bateman KG (1993). Antimicrobial drug use in cattle. In: Prescott JF and Baggot JD (eds) Antimicrobial Therapy in Veterinary Medicine, 2nd edn. Ames, IA: Iowa State University Press, pp. 456-468.
18. Bateman KG, Martin SW, Shewen PE and Menzies PI (1990). An evaluation of antimicrobial therapy for undifferentiated bovine respiratory disease. Canadian Veterinary Journal 31: 689-697.
19. Bentley OE and Cummins JM (1987). Efficacy of sulbactam, a betalactamase inhibitor, combined with ampicillin, in the therapy of ampicillin-resistant pneumonic pasteurellosis in feedlot calves. Canadian Veterinary Journal 28: 591-594.
20. Berggren KA, Baluyut CS, Simonson RR, Bemrick WJ and Maheswaran SK (1981). Cytotoxic effects of Pasteurella haemolytica on bovine neutrophils. American Journal of Veterinary Research 42: 1383-1388.
21. Berman AE, Kozlova NI and Morozevich GE (2003). Integrins: structure and signaling. Biochemistry (Moscow) 68: 1284-1299.
22. Biberstein EL (1978). Biotyping and serotyping Pasteurella haemolytica. In: Bergan T and Norris JR (eds) Methods in Microbiology. London: Academic Press, pp. 253-269.
23. Bingham DP, Moore R and Richards AB (1990). Comparison of DNA:DNA homology and enzymatic activity between Pasteurella haemolytica and related species. American Journal of Veterinary Research 51: 1161-1166.
24. Blackall PJ, Bojesen AM, Christensen H and Bisgaard M (2007). Reclassification of [Pasteurella] trehalosi as Bibersteinia trehalosi gen. nov., comb. nov. International Journal of Systematic and Evolutionary Microbiology 5: 666-674.
25. Blood DC, Radostits OM and Henderson JA (1983). Veterinary Medicine, 6th edn. London: Bailliere-Tindall.
26. Booker CW, Abutarbush SM, Schunicht OC, Jim GK, Perrett T, Wildman BK, Guichon PT, Pittman TJ, Jones C and Pollock CM (2007) Evaluation of the efficacy of tulathromycin as a metaphylactic antimicrobial in feedlot calves. Veterinary Therapeutics 8: 183-200.
27. Bowersock TL, Hogenesch H, Suckow M, Guimond P, Martin S, Borie D, Torregrosa S, Park H and Park K (1999). Oral vaccination of animals with antigens encapsulated in alginate microspheres. Vaccine 17: 1804-1811.
28. Bowland SL and Shewen PE (2000). Bovine respiratory disease: commercial vaccines currently available in Canada. Canadian Veterinary Journal 41: 33-48.
29. Breider MA, Walker RD, Hopkins FM, Schultz TW and Bowersock TL (1988). Pulmonary lesions induced by Pasteurella haemolytica in neutrophil sufficient and neutrophil deficient calves. Canadian Journal of Veterinary Research 52: 205-209.
30. Briggs RE and Tatum FM (1999). New mucosal vaccine in beef cattle imparts rapid resistance to pneumonic pasteurellosis after mass-medicating on feed. Presented at the Annual Meeting of United States Animal Health Association, San Diego, CA. www.usaha.org
31. Brogden KA, Debey B, Audibert F, Lehmkuhl H and Chedid L (1995). Protection of ruminants by Pasteurella haemolytica A1 capsular polysaccharide vaccines containing muramyl dipeptide analogs. Vaccine 13: 1677-1684.
32. Brogden KA, Lehmkuhl HD and Cutlip RC (1998). Pasteurella haemolytica complicated respiratory infections in sheep and goats. Veterinary Research 29: 233-254.
33. Brown GB, Bolin SR, Frank DE and Roth JA (1991). Defective function of leukocytes from cattle persistently infected with bovine viral diarrhea virus, and the influence of recombinant cytokines. American Journal of Veterinary Research 52: 381-387.
34. Brown Jr TT and Ananaba G (1988). Effect of respiratory infections caused by bovine herpesvirus-1 or parainfluenza-3 virus on bovine alveolar macrophage functions. American Journal of Veterinary Research 49: 1447-1451.
35. Carter GR, Chengappa MM and Roberts AW (1995). Essentials of Veterinary Microbiology. Baltimore, MD: Williams & Wilkins, pp. 171-179.
36. Chae CH, Gentry MJ, Confer AW and Anderson GA (1990). Resistance to host immune defense mechanisms afforded by capsular material of Pasteurella haemolytica, serotype 1. Veterinary Microbiology 25: 241-251.
37. Chang Y, Young R, Post D and Struck DK (1989). Identification and characterization of the Pasteurella haemolytica leukotoxin. Infection and Immunity 55: 2348-2354.
38. Clarke CR, Confer AW and Mosier DA (1998). In vivo effect of Pasteurella haemolytica infection on bovine neutrophil morphology. American Journal of Veterinary Research 59: 588-592.
39. Clinkenbeard KD and Upton ML (1991). Lysis of bovine platelets by Pasteurella haemolytica leukotoxin. American Journal of Veterinary Research 52: 453-457.
40. Clinkenbeard KD, Mosier DA and Confer AW (1989). Transmembrane pore size and role of cell swelling in cytotoxicity caused by Pasteurella haemolytica leukotoxin. Infection and Immunity 57: 420-425.
41. Confer AW and Simons KR (1986). Effects of Pasteurella haemolytica lipopolysaccharide on selected functions of bovine leukocytes. American Journal of Veterinary Research 47: 154-157.
42. Confer AW, Panciera RJ, Gentry MJ and Fulton RW (1986). Serum antibodies against Pasteurella haemolytica lipopolysaccharide: relationship to experimental bovine pneumonic pasteurellosis. American Journal of Veterinary Research 47: 1134-1138.
43. Confer AW, Simons KR, Panciera RJ, Mort AJ and Mosier DA (1989). Serum antibody response to carbohydrate antigens of Pasteurella haemolytica serotype 1: relation to experimentally induced bovine pneumonic pasteurellosis. American Journal of Veterinary Research 50: 98-105.
44. Confer AW, Fulton RW, Clinkenbeard KD and Driskell BA (1998). Duration of serum antibody responses following vaccination and revaccination of cattle with non-living commercial Pasteurella haemolytica vaccines. Vaccine 16: 1962-1970.
45. Confer AW, Ayalew S, Panciera RJ, Montelongo M, Whitworth LC and Hammer JD (2003). Immunogenicity of recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE and augmentation of a commercial vaccine. Vaccine 21: 2821-2829.
46. Confer AW, Ayalew S, Panciera RJ, Montelongo M and Wray JH (2006). Recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE enhances commercial M. haemolytica vaccine-induced resistance against serotype 6 challenge. Vaccine 24: 2248-2255.
47. Conlon JA and Shewen PE (1993). Clinical and serological evaluation of a Pasteurella haemolytica A1 capsular polysaccharide vaccine. Vaccine 11: 767-772.
48. Cooney BJ and Lo RY (1993). Three contiguous lipoprotein genes in Pasteurella haemolytica A1 which are homologous to a lipoprotein gene in Haemophilus influenzae type b. Infection and Immunity 61: 4682-4688.
49. Coote JG (1992). Structural and functional relationships among the RTX toxin determinants of gram-negative bacteria. FEMS Microbiology Reviews 8: 137-161.
50. Cudd LA, Ownby CL, Clarke CR, Sun Y and Clinkenbeard KD (2001). Effects of Mannheimia haemolytica leukotoxin on apoptosis and oncosis of bovine neutrophils. American Journal of Veterinary Research 62: 136-141.
51. Czuprynski CJ, Noel EF and Adlam C (1989). Modulation of bovine neutrophil antibacterial activities by Pasteurella haemolytica A1 purified capsular polysaccharide. Microbial Pathogenesis 6: 133-141.
52. Dassanayake RP, Maheswaran SK and Srikumaran S (2007). Monomeric expression of bovine beta2-integrin subunits reveals their role in Mannheimia haemolytica leukotoxininduced biological effects. Infection and Immunity 75: 5004-5010.
53. Davies RL and Donachie W (1996). Intra-specific diversity and host specificity within Pasteurella haemolytica based on variation of capsular polysaccharide, lipopolysaccharide and outer-membrane proteins. Microbiology 142: 1895-1907.
54. Davies RL and Baillie S (2003). Cytotoxic activity of Mannheimia haemolytica strains in relation to diversity of the leukotoxin structural gene lktA. Veterinary Microbiology 92: 263-279.
55. Davies RL, Whittam TS and Selander RK (2001). Sequence diversity and molecular evolution of the leukotoxin (lktA) gene in bovine and ovine strains of Mannheimia (Pasteurella) haemolytica. Journal of Bacteriology 183: 1394-1404.
56. Davies RL, Campbell S and Whittam TS (2002). Mosaic structure and molecular evolution of the leukotoxin operon (lktCABD) in Mannheimia (Pasteurella) haemolytica, Mannheimia glucosida, and Pasteurella trehalosi. Journal of Bacteriology 184: 266-277.
57. DeBey BM, Roth JA, Brogden KA, Cutlip RC, Stevens MG, Briggs RE and Kluge JP (1996). In vitro lymphocyte responses and gamma-interferon production as measures of cell-mediated immunity of cattle exposed to Pasteurella haemolytica. Canadian Journal of Veterinary Research 60: 263-270.
58. Deshpande MS, Ambagala TC, Ambagala AP, Kehrli Jr ME and Srikumaran S (2002). Bovine CD18 is necessary and sufficient to mediate Mannheimia (Pasteurella) haemolytica leukotoxin-induced cytolysis. Infection and Immunity 70: 5058-5064.
59. Donachie W (1999). Cattle pasteurellosis vaccine. Moredun Research Institute Annual Report for 1999, p. 10. www. moredun.org.uk
60. Ewers C, Lubke-Becker A and Wieler LH (2004). Mannheimia haemolytica and the pathogenesis of enzootic bronchopneumonia. Berliner und Münchener Tierä rztliche Wochenschrift 117: 97-115.
61. Farley H (1932). An epizoological study of shipping fever in Kansas. Journal of the American Veterinary Medical Association 52: 165-172.
62. Fedorova ND and Highlander SK (1997). Generation of targeted nonpolar gene insertions and operon fusions in Pasteurella haemolytica and creation of a strain that produces and secretes inactive leukotoxin. Infection and Immunity 65: 2593-2598.
63. Filion LG, Willson PJ, Bielfeldt-Ohmamn H, Babiuk LA and Thomson RG (1984). The possible role of stress in the induction of pneumonic pasteurellosis. Canadian Journal of Comparative Medicine 48: 268-274.
64. Frank GH (1984). Bacteria as etiologic agents in bovine respiratory disease. In: Loan RW (ed.) Bovine Respiratory Disease. College Station, TX: Texas A&M University Press.
65. Frank GH (1989). Pasteurellosis of cattle. In: Adlam C and Rutter JM (eds) Pasteurella and Pasteurellosis. London: Academic Press, pp. 197-222.
66. Frank GH and Briggs RE (1992). Colonization of the tonsils of calves with Pasteurella haemolytica. American Journal of Veterinary Research 53: 481-484.
67. Frank GH and Smith PC (1983). Prevalence of Pasteurella haemolytica in transported calves. American Journal of Veterinary Research 44: 981-985.
68. Frank GH and Tabatabai LB (1981). Neuraminidase activity of Pasteurella haemolytica isolates. Infection and Immunity 32: 1119-1122.
69. Frank GH, Briggs RE, Loan RW, Purdy CW and Zehr ES (1994). Serotype-specific inhibition of colonization of the tonsils and nasopharynx of calves with Pasteurella haemolytica serotype A1 after vaccination with the organism. American Journal of Veterinary Research 55: 1107-1110.
70. Frank GH, Briggs RE and Zehr ES (1995). Colonization of the tonsils and nasopharynx of calves by rifampicin-resistant Pasteurella haemolytica and its inhibition by vaccination. American Journal of Veterinary Research 56: 866-869.
71. Friend SC, Wilkie BN, Thomson RG and Barnum DA (1977). Bovine pneumonic pasteurellosis: experimental induction in vaccinated and nonvaccinated calves. Canadian Journal of Comparative Medicine 41: 77-83.
72. Gahmberg CG (1997). Leukocyte adhesion: CD11/CD18 integrins and intercellular adhesion molecules. Current Opinion in Cell Biology 9: 643-650.
73. Gatewood DM, Fenwick BW and Chengappa MM (1994). Growth-condition dependent expression of Pasteurella haemolytica A1 outer membrane proteins, capsule, and leukotoxin. Veterinary Microbiology 41: 221-233.
74. Gentry MJ, Confer AW and Panciera RJ (1985). Serum neutralization of cytotoxin from Pasteurella haemolytica, serotype 1 and resistance to experimental bovine pneumonic pasteurellosis. Veterinary Immunology and Immunopathology 9: 239-250.
75. Gibbs HA, Allan EM, Wiseman A and Selman IE (1984). Experimental production of bovine pneumonic pasteurellosis. Research in Veterinary Science 37: 154-166.
76. Gilmour NJ, Donachie W, Sutherland AD, Gilmour JS, Jones GE and Quirie M (1991). Vaccine containing iron-regulated proteins of Pasteurella haemolytica A2 enhances protection against experimental pasteurellosis in lambs. Vaccine 9: 137-140.
77. Gorham PE, Carroll LH, McAskill JW, Watkins LE, Ose EE, Tonkinson LV and Merrill JK (1990). Tilmicosin as a single injection treatment for respiratory disease of feedlot cattle. Canadian Veterinary Journal 31: 826-829.
78. Grey CL and Thomson RG (1971). Pasteurella haemolytica in the tracheal air of calves. Canadian Journal of Comparative Medicine 35: 121-128.
79. Gonzalez-Rayos C, Lo RY, Shewen PE and Beveridge TJ (1986). Cloning of a serotype-specific antigen from Pasteurella haemolytica A1. Infection and Immunity 53: 505-510.
80. Hamdy AH, King NB and Trapp AL (1965). Attempted immunization of cattle against shipping fever: a field trial. American Journal of Veterinary Research 26: 897-902.
81. Harland RJ, Jim GK, Guichon PT, Townsend HGG and Janzen ED (1991). Efficacy of parenteral antibiotics for disease prophylaxis in feedlot calves. Canadian Veterinary Journal 32: 163-168.
82. Highlander SK, Chidambaram M, Engler MJ and Weinstock GM (1989). DNA sequence of the Pasteurella haemolytica leukotoxin gene cluster. DNA 8: 15-28.
83. Highlander SK, Fedorova ND, Dusek DM, Panciera R, Alvarez LE and Rinehart C (2000). Inactivation of Pasteurella (Mannheimia) haemolytica leukotoxin causes partial attenuation of virulence in a calf challenge model. Infection and Immunity 68: 3916-3922.
84. Hirsh DC and Zee YC (1999). Veterinary Microbiology. Boston, MA: Blackwell Scientific Publications, pp. 135-140.
85. Hjerpe CA (1990). Bovine vaccines and herd vaccination programs. Veterinary Clinics of North America: Food Animal Practice 6: 171-260.
86. Hoar BR, Jelinski MD, Ribble CS, Janzen ED and Johnson JC (1998). A comparison of the clinical field efficacy and safety of florfenicol and tilmicosin for the treatment of undifferentiated bovine respiratory disease of cattle in western Canada. Canadian Veterinary Journal 39: 161-166.
87. Issartel JP, Koronaskis V and Hughes C (1991). Activation of Escherichia coli prohaemolysin to the mature toxin by acyl carrier protein-dependent fatty acylation. Nature 351: 759-761.
88. Jaramillo L, Diaz F, Hernandez P, Debray H, Trigo F, Mendoza G and Zenteno E (2000). Purification and characterization of an adhesin from Pasteurella haemolytica. Glycobiology 10: 31-37.
89. Jericho KWF (1979). Update on pasteurellosis in young cattle. Canadian Veterinary Journal 20: 333-335.
90. Jeyaseelan S, Hsuan SL, Kannan MS, Walcheck B, Wang JF, Kehrli ME, Lally ET, Sieck GC and Maheswaran SK (2000). Lymphocyte function-associated antigen 1 is a receptor for Pasteurella haemolytica leukotoxin in bovine leukocytes. Infection and Immunity 68: 72-79.
91. Jeyaseelan S, Kannan MS, Briggs RE, Thumbikat P and Maheswaran SK (2001). Mannheimia haemolytica leukotoxin activates a nonreceptor tyrosine kinase signaling cascade in bovine leukocytes, which induces biological effects. Infection and Immunity 69: 6131-6139.
92. Jeyaseelan S, Sreevatsan S and Maheswaran SK (2002). Role of Mannheimia haemolytica leukotoxin in the pathogenesis of bovine pneumonic pasteurellosis. Animal Health Research Reviews 3: 69-82.
93. Jim GK, Booker CW, Guichon PT, Schunicht OC, Wildman BK, Johnson JC and Lockwood PW (1999). A comparison of florfenicol and tilmicosin for the treatment of undifferentiated fever in feedlot calves in western Canada. Canadian Veterinary Journal 40: 179-184.
94. Jim K, Guichon T and Shaw G (1988). Protecting calves from pneumonic pasteurellosis. Veterinary Medicine 83: 1084-1087.
95. Jubb KVF and Kennedy PC (1970). Pathology of Domestic Animals, 2nd edn. New York: Academic Press.
96. Keiss RE, Will DH and Collier JR (1964). Skin toxicity and hemodynamic properties of endotoxin derived from Pasteurella haemolytica. American Journal of Veterinary Research 25: 935-941.
97. Kelly AP and Janzen ED (1986). A review of morbidity and mortality rates and disease occurrence in North American feedlot cattle. Canadian Veterinary Journal 27: 496-500.
98. Kesler DJ and Bechtol DT (1999). Efficacy of sustained release needle-less ceftiofur sodium implants in treating calves with bovine respiratory disease. Zentralblatt fü r Veterinärmedizin [B] 46: 25-35.
99. Kiorpes AL, Butler DG, Dubielzig RR and Beck KA (1988). Enzootic pneumonia in calves: clinical and morphological features. Compendium for the Continuing Education of the Practicing Veterinarian 10: 248-260.
100. Kitt T (1885). Uber eine experimentelle de Rinderseuche ahnliche Infektionskrankheit. Sitzungsberichte der Gesellschaft fü r Morphologie und Physiologic in München. pp. 140-168.
101. Lainson FA, Murray J, Davis RC and Donachie W (1996). Characterization of epitopes involved in the neutralization of Pasteurella haemolytica serotype A1 leukotoxin. Microbiology 142: 2499-2507.
102. Lally ET, Kieba IR, Sato A, Green C, Rosenbloom J, Korostoff J, Wang JF, Shenker BJ, Otrlepp S, Robinson MK and Billings PC (1997). RTX toxins recognize a beta2 integrin on the surface of human target cells. Journal of Biological Chemistry 272: 30463-30469.
103. Lally ET, Hill RB, Kieba IR and Korostoff J (1999). The interaction between RTX toxins and target cells. Trends in Microbiology 7: 356-361.
104. Lee CW and Shewen PE (1996). Evidence of bovine immunoglobulin G1 (IgG1) protease activity in partially purified culture supernate of Pasteurella haemolytica A1. Canadian Journal of Veterinary Research 60: 127-132.
105. Lee CW, Shewen PE, Cladman WM, Conlon JA, Mellors A and Lo RY (1994). Sialoglycoprotease of Pasteurella haemolytica A1: detection of antisialoglycoprotease antibodies in sera of calves. Canadian Journal of Veterinary Research 58: 93-98.
106. Lee RW, Strommer J, Hodgins D, Shewen PE, Niu Y and Lo RYC (2001). Towards development of an edible vaccine against bovine pneumonic pasteurellosis using transgenic white clover expressing a Mannheimia haemolytica leukotoxin 50 fusion protein. Infection and Immunity 69: 5786-5793.
107. Li J and Clinkenbeard KD (1999). Lipopolysaccharide complexes with Pasteurella haemolytica leukotoxin. Infection and Immunity 67: 2920-2927.
108. Li J, Clinkenbeard KD and Ritchey JW (1999). Bovine CD18 identified as a species specific receptor for Pasteurella haemolytica leukotoxin. Veterinary Microbiology 67: 91-97.
109. Libersa H, Van Huffel B and Madelenat A (1995). Evaluation of the efficacy of a new antibiotic, florfenicol (Nuflor) in the treatment of bovine respiratory disease. Recueil de Médecine Vétérinaire 171: 39-44.
110. Lillie LE and Thomson RG (1972). The pulmonary clearance of bacteria by calves and mice. Canadian Journal of Comparative Medicine 36: 129-137.
111. Lo RY (1990). Molecular characterization of cytotoxins produced by Haemophilus, Actinobacillus, Pasteurella. Canadian Journal of Veterinary Research 54: S33-S35.
112. Lo RYC and Shewen PE (1991). The genus Pasteurella. In: Balows A, Truper HG, Dworkin M, Harder W and Schliefer KH (eds) The Prokaryotes, 2nd edn. New York: Springer-Verlag.
113. Lo RYC, Shewen PE, Strathdee CA and Greer CN (1985). Cloning and expression of the leukotoxin gene of Pasteurella haemeolytica A1 in Escherichia coli K-12. Infection and Immunity 50: 557-571.
114. Lo RYC, Strathdee CA and Shewen PE (1987). Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1. Infection and Immunity 55: 1987-1996.
115. Lo RY, Strathdee CA, Shewen PE and Cooney BJ (1991). Molecular studies of Ssa1, a serotype-specific antigen of Pasteurella haemolytica A1. Infection and Immunity 59: 3398-3406.
116. Lopez A, Thomson RG and Savan M (1976). The pulmonary clearance of Pasteurella haemolytica in calves infected with bovine parainfluenza 3 virus. Canadian Journal of Comparative Medicine 40: 385-391.
117. Martin SW (1983). Vaccination: is it effective in preventing respiratory disease or influencing weight gains in feedlot calves? Canadian Veterinary Journal 24: 10-19.
118. Martin SW (1989). An overview of field trials in veterinary medicine. Canadian Veterinary Journal 30: 302-303.
119. Mechor GD, Jim GK and Janzen ED (1988). Comparison of penicillin, oxytetracycline, and trimethoprim-sulfadoxine in the treatment of acute undifferentiated bovine respiratory disease. Canadian Veterinary Journal 29: 438-443.
120. Miller AW, Howard LH, Bayard ES, Smith RW, Stanard SJ, Jones JD, Hilton G, Killham BJ and Truam J (1927). Report of committee on miscellaneous transmissible diseases. Journal of the American Veterinary Medical Association 70: 952-955.
121. Morck DW, Raybould TJ, Acres SD, Babiuk LA, Nelligan J and Costerton JW (1987). Electron microscopic description of glycocalyx and fimbriae on the surface of Pasteurella haemolytica-A1. Canadian Journal of Veterinary Research 51: 83-88.
122. Morck DW, Watts TC, Acres SD and Costerton JW (1988). Electron microscopic examination of cells of Pasteurella haemolytica A1 in experimentally infected cattle. Canadian Journal of Veterinary Research 52: 343-348.
123. Morck DW, Olson ME, Acres SD, Daoust PY and Costerton JW (1989). Presence of bacterial glycocalyx and fimbriae on Pasteurella haemolytica in feedlot cattle with pneumonic pasteurellosis. Canadian Journal of Veterinary Research 53: 167-171.
124. Morck DW, Ellis BD, Domingue PA, Olson ME and Costerton JW (1991). In vivo expression of iron regulated outermembrane proteins in Pasteurella haemolytica-A1. Microbial Pathogenesis 11: 373-378.
125. Morton RJ, Simons KR and Confer AW (1996). Major outer membrane proteins of Pasteurella haemolytica serovars 1-15: comparison of separation techniques and surfaceexposed proteins on selected serovars. Veterinary Microbiology 51: 319-330.
126. Mosier DA, Confer AW and Panciera RJ (1989). The evolution of vaccines for bovine pneumonic pasteurellosis. Research in Veterinary Science 47: 1-10.
127. Mosier DA, Simons KR and Vestweber JG (1995). Passive protection of calves with Pasteurella haemolytica antiserum. American Journal of Veterinary Research 56: 1317-1321.
128. Mosier DA, Panciera RJ, Rogers DP, Uhlich GA, Butine MD, Confer AW and Basaraba RJ (1998). Comparison of serologic and protective responses induced by two Pasteurella vaccines. Canadian Journal of Veterinary Research 62: 178-182.
129. Murphy GL, Whitworth LC, Clinkenbeard KD and Clinkenbeard PA (1995). Haemolytic activity of Pasteurella haemolytica leukotoxin. Infection and Immunity 63: 3209-3212.
130. Nardini PM, Mellors A and Lo RY (1998). Characterization of a fourth lipoprotein from Pasteurella haemolytica A1 and its homology to the OmpA family of outer membrane proteins. FEMS Microbiology Letters 165: 71-77.
131. Newsome IE and Cross F (1932). Some bipolar organisms found in pneumonia in sheep. Journal of the American Veterinary Medical Association 80: 711-719.
132. Ogunnariwo JA and Schryvers AB (1990). Iron acquisition in Pasteurella haemolytica: expression and identification of a bovine-specific transferrin receptor. Infection and Immunity 58: 2091-2097.
133. Orrenius S, Zhivotovsky B and Nicotera P (2003). Regulation of cell death: the calcium-apoptosis link. Nature Reviews. Molecular Cell Biology 4: 552-565.
134. Pandher K, Confer AW and Murphy GL (1998). Genetic and immunologic analyses of PlpE, a lipoprotein important in complement-mediated killing of Pasteurella haemolytica serotype 1. Infection and Immunity 66: 5613-5619.
135. Pandher K, Murphy GL and Confer AW (1999). Identification of immunogenic, surface-exposed outer membrane proteins of Pasteurella haemolytica serotype 1. Veterinary Microbiology 65: 215-226.
136. Potter AA, Schryvers AB, Ogunnariwo JA, Hutchins WA, Lo RY and Watts T (1999). Protective capacity of the Pasteurella haemolytica transferrin-binding proteins TbpA and TbpB in cattle. Microbial Pathogenesis 27: 197-206.
137. Purdy CW, Livingston CW and Frank GH (1986). A live Pasteurella haemolytica vaccine efficacy trial. Journal of the American Veterinary Medical Association 188: 589-591.
138. Purdy CW, Richards AB and Foster GS (1991). Market stressassociated changes in serum complement activity in feeder calves. American Journal of Veterinary Research 52: 1842-1847.
139. Purdy CW, Raleigh RH, Collins JK, Watts JL and Straus DC (1997). Serotyping and enzyme characterizations of Pasteurella haemolytica and Pasteurella multocida isolates recovered from pneumonic lungs of stressed feeder calves. Current Microbiology 34: 244-249.
140. Quinn PJ (1994). Clinical Veterinary Microbiology. London: Wolfe, pp. 254-258.
141. Radostits OM, Blood DC and Gay CC (1994). Veterinary Medicine, 8th edn. London: Bailliere Tindall.
142. Ribble CS (1989). Design considerations in clinical trials. Canadian Veterinary Journal 30: 292-294.
143. Ribble CS, Meek AH, Shewen PE, Guichon PT and Jim GK (1995a). Effect of pretransit mixing on fatal fibrinous pneumonia in calves. Journal of the American Veterinary Medical Association 207: 616-619.
144. Ribble CS, Meek AH, Jim GK and Guichon PT (1995b). The pattern of fatal fibrinous pneumonia (shipping fever) affecting calves in a large feedlot in Alberta (1985-1988. Canadian Veterinary Journal 36: 753-757.
145. Rossi C and Kiesel GK (1977). Susceptibility of bovine macrophages and tracheal-ring cultures to bovine viruses. American Journal of Veterinary Research 38: 1705-1708.
146. Schipper IA and Kelling CL (1971). Shipping fever prophylaxis: comparison of vaccine and antibiotics administered following weaning. Canadian Veterinary Journal 12: 172-175.
147. Schumann FJ, Janzen ED and McKinnon JJ (1990). Prophylactic tilmicosin medication of feedlot calves at arrival. Canadian Veterinary Journal 31: 285-288.
148. Schunicht OC, Booker CW, Guichon PT, Jim KG, Wildman BK, Pitman TJ and Perrett T (2007). An evaluation of the relative efficacy of tulathromycin for the treatment of undifferentiated fever in feedlot calves in Nebraska. Canadian Veterinary Journal 48: 600-606.
149. Shewen PE and Conlon JA (1993). Pasteurella. In: Gyles CL and Thoen CO (eds) Pathogenesis of Bacterial Infections in Animals, 2nd edn. Ames, IA: Iowa State University, pp. 216-225.
150. Shewen PE and Wilkie BN (1982). Cytotoxin of Pasteurella haemolytica acting on bovine leukocytes. Infection and Immunity 35: 91-94.
151. Shewen PE and Wilkie BN (1983). Pasteurella haemolytica cytotoxin: production by recognized serotypes and neutralization by type-specific rabbit antisera. American Journal of Veterinary Research 44: 715-719.
152. Shewen PE and Wilkie BN (1985). Evidence for the Pasteurella haemolytica cytotoxin as a product of actively growing bacteria. American Journal of Veterinary Research 46: 1212-1214.
153. Shewen PE and Wilkie BN (1988). Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica. Canadian Journal of Veterinary Research 52: 30-36.
154. Shewen PE, Sharp A and Wilkie BN (1988). Efficacy testing a Pasteurella haemolytica extract vaccine. Veterinary Medicine 83: 1078-1083.
155. Slocombe RF, Derksen FJ, Robinson NE, Trapp A, Gupta A and Newman JP (1984). Interactions of cold stress and Pasteurella haemolytica in the pathogenesis of pneumonic pasteurellosis in calves: method of induction and hematologic and pathologic changes. American Journal of Veterinary Research 45: 1757-1763.
156. Slocombe RF, Malark J, Ingersoll R, Derksen FJ and Robinson NE (1985). Importance of neutrophils in the pathogenesis of acute pneumonic pasteurellosis in calves. American Journal of Veterinary Research 46: 2253-2258.
157. Smith CK, Davidson JN and Henry CW (1985). Evaluating a live vaccine for Pasteurella haemolytica in dairy calves. Veterinary Medicine 80: 78-88.
158. Smith GR (1961). The characteristics of two types of Pasteurella haemolytica associated with different pathological conditions of sheep. Journal of Pathology and Bacteriology 81: 431-440.
159. Sneath PH and Stevens M (1990). Actinobacillus rossii sp. nov., Actinobacillus seminis sp. nov., nom. rev., Pasteurella bettii sp. nov., Pasteurella lymphangitidis sp. nov., Pasteurella mairi sp. nov., and Pasteurella trehalosi sp. nov. International Journal of Systematic Bacteriology 40: 148-153.
160. Squire PG, Smiley DW and Croskell RB (1984). Identification and extraction of Pasteurella haemolytica membrane proteins. Infection and Immunity 45: 667-673.
161. Srinand S, Hsuan SL, Yoo HS, Maheswaran SK, Ames TR and Werdin RE (1996). Comparative evaluation of antibodies induced by commercial Pasteurella haemolytica vaccines using solid phase immunoassays. Veterinary Microbiology 49: 181-195.
162. Strathdee CA and Lo RY (1987). Extensive homology between the leukotoxin of Pasteurella haemolytica A1 and the alpha-hemolysin of Escherichia coli. Infection and Immunity 55: 3233-3236.
163. Strathdee CA and Lo RY (1989). Cloning, nucleotide sequence and characterization of genes encoding the secretion function of the Pasteurella haemolytica leukotoxin determinant. Journal of Bacteriology 171: 916-928.
164. Straus DC and Purdy CW (1994). In vivo production of neuraminidase by Pasteurella haemolytica A1 in goats after transthoracic challenge. Infection and Immunity 62: 4675-4678.
165. Straus DC, Purdy CW, Loan RW, Briggs RF and Frank GH (1998). In vivo production of neuraminidase by Pasteurella haemolytica in market stressed cattle after natural infection. Current Microbiology 37: 240-244.
166. Sun Y, Clinkenbeard KD, Cudd LA, Clarke CR and Clinkenbeard PA (1999). Correlation of Pasteurella haemolytica leukotoxin binding with susceptibility to intoxication of lymphoid cells from various species. Infection and Immunity 67: 6264-6269.
167. Sun Y, Clinkenbeard KD, Ownby CL, Cudd LA, Clarke CR and Highlander SK (2000). Ultrastructural characterization of apoptosis in bovine lymphocytes exposed to Pasteurella haemolytica leukotoxin. American Journal of Veterinary Research 61: 51-56.
168. Tatum FM, Briggs RE, Sreevatsan SS, Zehr ES, Hsuan SL, Whiteley LO, Ames TR and Maheswaran SK (1998). Construction of an isogenic leukotoxin deletion mutant of Pasteurella haemolytica serotype 1: characterization and virulence. Microbial Pathogenesis 24: 37-46.
169. Thomson RG (1984). Pathogenesis of pneumonia in feedlot cattle. In: Loan RW (ed.) Bovine Respiratory Disease. College Station, TX: Texas A&M University Press.
170. Thorlakson B, Martin W and Peters D (1990). A field trial to evaluate the efficacy of a commercial Pasteurella haemolytica bacterial extract in preventing bovine respiratory disease. Canadian Veterinary Journal 31: 573-579.
171. Ulevitch RJ and Tobias PS (1995). Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annual Review of Immunology 13: 437-457.
172. Van Donkersgoed J (1992). Meta-analysis of field trials of antimicrobial mass medication for prophylaxis of bovine respiratory disease in feedlot cattle. Canadian Veterinary Journal 33: 786-795.
173. Van Donkersgoed J, Ribble CS, Boyer LG and Townsend HG (1993a). Epidemiological study of enzootic pneumonia in dairy calves in Saskatchewan. Canadian Journal of Veterinary Research 57: 247-254.
174. Van Donkersgoed J, Schumann FJ, Harland RJ, Potter AA and Janzen ED (1993b). The effect of route and dosage of immunization on the serological response to a Pasteurella haemolytica and Haemophilus somnus vaccine in feedlot calves. Canadian Veterinary Journal 34: 731-735.
175. Van Donkersgoed J, Potter AA, Mollinson B and Harland RJ (1994). The effect of a combined Pasteurella haemolytica and Haemophilus somnus vaccine and a modified-live bovine respiratory syncytial virus vaccine against enzootic pneumonia in young beef calves. Canadian Veterinary Journal 35: 239-241.
176. Van Donkersgoed J, Guenther C, Evans BN, Potter AA and Harland RJ (1995). Effects of various vaccination protocols on passive and active immunity to Pasteurella haemolytica and Haemophilus somnus in beef calves. Canadian Veterinary Journal 36: 424-429.
177. Varma KJ, Lockwood PW, Cosgrove SB and Rogers ER (1998). Pharmacology, safety, and clinical efficacy of Nuflor (florfenicol) following subcutaneous administration to cattle. Proceedings of the Symposium ‘Nuflor-New Therapeutic Applications’ held in conjunction with the XX World Buiatrics Congress, Sydney, Australia, pp. 13-19.
178. Vogel GJ, Laudert SB, Zimmermann A, Guthrie CA, Mechor GD and Moore GM (1998). Effects of tilmicosin on acute undifferentiated respiratory tract disease in newly arrived feedlot cattle. Journal of the American Veterinary Medical Association 212: 1919-1924.
179. Wang JF, Kieba IR, Korostoff J, Guo TL, Yamaguchi N, Rozmiarek H, Billings PC, Shenker BJ and Lally ET (1998a). Molecular and biochemical mechanisms of Pasteurella haemolytica leukotoxin-induced cell death. Microbial Pathogenesis 25: 317-331.
180. Wang Z, Clarke C and Clinkenbeard K (1998b). Pasteurella haemolytica leukotoxin-induced increase in phospholipase A2 activity in bovine neutrophils. Infection and Immunity 66: 1885-1890.
181. Watts JL, Yancey Jr RJ, Salmon SA and Case CA (1994). A 4-year survey of antimicrobial susceptibility trends for isolates from cattle with bovine respiratory disease in North America. Journal of Clinical Microbiology 32: 725-731.
182. Weiss DJ, Bauer MC, Whiteley LO, Maheswaran SK and Ames TR (1991). Changes in blood and bronchoalveolar lavage fluid components in calves with experimentally induced pneumonic pasteurellosis. American Journal of Veterinary Research 52: 337-344.
183. Wellman NG and O'Connor AM (2007). Meta-analysis of treatment of cattle with bovine respiratory disease with tulathromycin. Journal of Veterinary Pharmacology and Therapeutics 30: 234-241.
184. Welsh RD, Dye LB, Payton ME and Confer AW (2004). Isolation and antimicrobial susceptibilities of bacterial pathogens from bovine pneumonia: 1994-2002. Journal of Veterinary Diagnostic Investigation 16: 426-431.
185. Whiteley LO, Maheswaran SK, Weiss DJ, Ames TR and Kannan MS (1992). Pasteurella haemolytica A1 and bovine respiratory disease: pathogenesis. Journal of Veterinary Internal Medicine 6: 11-22.
186. Wilkie BN, Markham RJ and Shewen PE (1980). Response of calves to lung challenge exposure with Pasteurella haemolytica after parenteral or pulmonary immunization. American Journal of Veterinary Research 41: 1773-1778.
187. Wilson S.H. Why are meaningful field trials difficult to achieve for bovine respiratory disease vaccines? Canadian Veterinary Journal 30: 299-302.
188. Woldehiwet Z and Sharma R (1992). Evidence of immunosuppression by bovine respiratory syncytial virus. Scandinavian Journal of Immunology 11: 75-80.
189. Younan M and Fodor L (1995). Characterization of a new Pasteurella haemolytica serotype (A17). Research in Veterinary Science 58: 98.
190. Young C (1995). Antimicrobial metaphylaxis for undifferentiated bovine respiratory disease. Compendium on Continuing Education for the Practicing Veterinarian 17: 133-142.